期刊文献+

慢性阻塞性肺疾病临床防治与研究热点问题 被引量:46

下载PDF
导出
摘要 慢性阻塞性肺疾病(chronicobstructivepulmonarydisease,简称慢阻肺)是一种以持续气流受限为特征的可以预防和治疗的疾病,该疾病不但严重影响患者的生活质量,而且给患者个人、社会及家庭都带来了沉重的经济负担。我国对7个地区20245名成年人进行调查,结果显示40岁以上人群中慢阻肺的患病率高达8.2%,推算我国约有3800万慢阻肺患者。
出处 《实用医学杂志》 CAS 北大核心 2014年第1期1-3,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献17

  • 1Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey[J]. Am J Respir Crit Care Med, 2007, 176(8): 753-760.
  • 2中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国医学前沿杂志(电子版),2011,6(3):54109.
  • 3钟南山.早发现、早诊断和早干预应是我国慢性阻塞性肺疾病防治的主要研究方向[J].中华结核和呼吸杂志,2012,35(4):243-245. 被引量:57
  • 4VestboJ, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. AmJ Respir Crit Care Med,2013, 187(4): 347-365.
  • 5Calverley PM, AndersonJA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease[J]. N EnglJ Med,2007,356(8): 775-789.
  • 6Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease[J]. N Eng!J Med,2008,359 (15): 1543-1554.
  • 7VestboJ, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD[J]. N Eng!J Med,2011 365(13): 1184-1192.
  • 8HurstJR, VestboJ, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease[J]. N Eng!J Med, 2010,363 (12): 1128-1138.
  • 9Jenkins CR,Jones PW, Calverley PM, et al. Efficacy of salmeterollfluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study[J]. Respir Res, 2009, 10: 59.
  • 10Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFt): a prespecified subgroup analysis of a randomised controlled trial[J]. Lancet, 374(9696): 1171-1178.

二级参考文献19

  • 1Zhong N,Wang C,Yao W. Prevalence of chronic obstructive pulmonary discas(c) in China:a large,population-based survey[J].American Journal of Respiratory and Critical Care Medicine,2007,(8):753-760.doi:10.1164/rccm.200612-1749OC.
  • 2GOLD Executive Committee. Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease (Revised 2011)[OL].http://www.goldcopd.com,2012.
  • 3Hogg JC,Chu F,Utokaparch S. The nature of small-airway obstruction in chronic obstructive pulmonary disease[J].New England Journal of Medicine,2004.2645-2653.doi:10.1056/NEJMoa032158.
  • 4Ley-Zaporozhan J,Kauczor HU. Imaging of airways:chronic obstructive puhmonary disease[J].Radiologic Clinics of North America,2009,(2):331-342.doi:10.1016/j.rcl.2008.11.012.
  • 5Fain SB,Panth SR,Evans MD. Early emphysematous changes in asymptomatic smokers:detection with 3He MR imaging[J].Radiology,2006.875-883.doi:10.1148/radiol.2393050111.
  • 6Swanney MP,Ruppel G,Enright PL. Using the lower limit of normal for the FEVI/FVC ratio reduces the misclassification of airway obstruction[J].Thorax,2008.1046-1051.doi:10.1136/thx.2008.098483.
  • 7Stanojevic S,Wade A,Stocks J. Reference ranges for spiromctry across all ages:a new approach[J].American Journal of Respiratory and Critical Care Medicine,2008.253-260.
  • 8Enright P,Brusasco V. Counterpoint:should we abandon FEV1/FVC 《 0.70 to detect airway obstruction[J].Yes Chest,2010.1040-1042.
  • 9Mohamed Hoesein FA,Zanen P,Lammers JW. Lower limit of normal or FEVI/FVC 《 0.70 in diagnosing COPD:an evidencebased review[J].Respiratory Medicine,2011.907-915.
  • 10Agusti A,Calverley PM,Celli B. Characterisation of COPD heterogeneity in the ECLIPSE cohort[J].Respiratory Research,2010.122.

共引文献168

同被引文献443

引证文献46

二级引证文献455

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部